graft versus host disease (GVHD) | Aplastic Anemia & MDS International Foundation

graft versus host disease (GVHD)

2020 National Patient & Family Conference (virtual)

AAMDSIF is hosting the 2020 National Patient & Family Conference ONLINE over three days, July 17 - 19, 2020. The Conference will feature three days of educational workshops, interesting speakers and support groups for patients with

Save the date!
Event Date: 
Fri, 07/17/2020 to Sun, 07/19/2020

Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease

Hematopoietic cell transplantation (HCT) is an established therapeutic modality for high risk hematological malignancies in adults and children. The primary cause of morbidity and mortality after HCT is graft versus host disease (GVHD), affecting up to 70% of patients even with current prophylaxis and directly accounting for approximately a third of regimen-related death. Currently, pharmacologic prophylaxis consists of a calcineurin inhibitor and methotrexate, a drug combination introduced around 40 years ago.

CD24Fc for the Prevention of Acute GVHD Following Myeloablative HSCT (CATHY)

The study is designed as a randomized, placebo-controlled, double blind, multicenter, phase III trial comparing two acute graft-versus-host disease (aGVHD) prophylaxis regimens: CD24Fc/tacrolimus / methotrexate (CD24Fc/Tac/MTX) versus placebo/tacrolimus / methotrexate (placebo/Tac/MTX) in the setting of myeloablative conditioning (MAC), matched

2020 Patient & Family Virtual Conference

About

Due to the coronavirus (COVID-19) pandemic, AAMDSIF made the decision to move our conferences online in order to protect the health of our patients, families, caregivers and faculty.

We would like to acknowledge the support of our many generous patients, families and caregivers as well as our corporate partners including Celgene, Alexion, Novartis, Genentech, Jazz Pharmaceuticals, Apellis and Acceleron.

Event Date: 
Sat, 04/25/2020
Conference Event Type: 

National Conference 2020 Virtual March for Marrow

We've gone VIRTUAL!
In light of the spread of the Coronavirus (COVID-19) and with the health and well-being of our patients, family members, friends and faculty as our top priority, AAMDSIF has decided to hold our March for Marrow as a VIRTUAL WALK! 

Event Date: 
Sat, 07/18/2020
Community Event Type: 

March for Marrow 5K Walk Milwaukee, Wisconsin 2020

Join us for a morning of fun, remembrance, and awareness at our 8th annual March for Marrow Walk Milwaukee.  For 35 years, the

Event Date: 
Sat, 05/30/2020
Community Event Type: 

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

Background:

2019 Patient & Family Conference (Jacksonville, Florida)

AAMDSIF in partnership with the Mayo Clinic Jacksonville hosted our final

Event Date: 
Sat, 11/16/2019
Conference Event Type: